Em

Fertility crisis: why IVF isn't working

Leslie Schrock, Deborah, Em, Catherine Braille, Dr. Hayashi Katsuhiko, Matt Chrysalof

Driven by a global market exceeding $20 billion and rising infertility rates among delayed planners, the assisted reproductive technology sector currently relies on egg freezing while facing criticism over success rate transparency and physical risks. Emerging research into in vitro gametesis (IVG), led by scientists like Dr. Katsuhiko Hayashi and venture-backed firms such as Conception, aims to bypass these limitations by creating viable eggs from skin cells for aging populations and same-sex couples, despite unresolved ethical and genetic safety hurdles. Parallel investigations into biological aging mechanisms suggest future pharmaceutical interventions could eventually halt the decline of egg quality, though such applications remain distant from clinical reality.